​

Imunon (IMNN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IMNN Stock Rating

Imunon stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

IMNN Price Target Upside V Benchmarks

TypeNameUpside
StockImunon-
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$4.72$4.72$4.72
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25111--3
Sep, 25121--4
Aug, 25121--4
Jul, 25121--4
Jun, 25121--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 23, 2024EF HuttonBuyinitialise
Aug 05, 2024Alliance Global PartnersBuyBuyhold
May 14, 2024H.C. WainwrightBuyBuyhold
Apr 01, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-2K $-2K $-1K $-800 $-400 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-10.08$-3.60$-5.03$-2.16$-1.62K----
Avg Forecast$-10.95$-3.40$-4.16$-2.23$-1.68$-1.13$-0.90$-0.88$-0.37
High Forecast$-10.95$-3.40$-4.16$-2.07$-1.63$-0.77$-0.74$-0.86$-0.37
Low Forecast$-10.95$-3.40$-4.16$-2.38$-1.74$-1.35$-1.17$-0.89$-0.37
Surprise %-7.95%5.88%20.91%-3.14%96209.52%----

Revenue Forecast

$0 $7M $14M $21M $28M $35M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$500.00K$500.00K$500.00K------
Avg Forecast$500.00K$458.33K$500.00K$125.00K$62.50K$10.43M$3.93M$7.33M$33.43M
High Forecast$500.00K$458.33K$500.00K$125.00K$62.50K$10.43M$3.93M$7.33M$33.43M
Low Forecast$500.00K$458.33K$500.00K$125.00K$62.50K$10.43M$3.93M$7.33M$33.43M
Surprise %-9.09%-------

Net Income Forecast

$-20B $-16B $-12B $-8B $-4B $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-21.48M$-20.77M$-35.90M$-19.51M$-18.62B----
Avg Forecast$-99.05M$-30.75M$-37.66M$-19.51M$-15.24M$-9.58M$-8.63M$-7.93M$-3.30M
High Forecast$-99.05M$-30.75M$-37.66M$-18.75M$-14.74M$-6.96M$-6.68M$-7.81M$-3.30M
Low Forecast$-99.05M$-30.75M$-37.66M$-21.56M$-15.74M$-12.21M$-10.58M$-8.05M$-3.30M
Surprise %-78.31%-32.47%-4.68%-122069.12%----

IMNN Forecast FAQ

Is Imunon stock a buy?

Imunon stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Imunon is a favorable investment for most analysts.

What is Imunon's price target?

Imunon's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $4.72.

How does Imunon stock forecast compare to its benchmarks?

Imunon's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Imunon over the past three months?

  • October 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Imunon’s EPS forecast?

Imunon's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.13, marking a -99.93% decrease from the reported $-1.618K in 2024. Estimates for the following years are $-0.9 in 2026, $-0.88 in 2027, and $-0.37 in 2028.

What is Imunon’s revenue forecast?

Imunon's average annual revenue forecast for its fiscal year ending in December 2025 is $10.43M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $3.93M, followed by $7.33M for 2027, and $33.43M for 2028.

What is Imunon’s net income forecast?

Imunon's net income forecast for the fiscal year ending in December 2025 stands at $-9.583M, representing a -99.95% decrease from the reported $-18.62B in 2024. Projections indicate $-8.634M in 2026, $-7.93M in 2027, and $-3.302M in 2028.